Falintolol

{{Chembox

| ImageFile = Falintolol.svg

| ImageSize = 200px

| ImageAlt =

| PIN = (2Ξ)-1-(tert-Butylamino)-3-{[(E)-(1-cyclopropylethylidene)amino]oxy}propan-2-ol

| OtherNames =

|Section1={{Chembox Identifiers

| CASNo = 106401-52-9

| CASNo_Ref = {{Cascite|changed|CAS}}

| ChEMBL = 111103

| PubChem = 6917762

| ChemSpiderID = 16736664

| UNII = 82MXJ61S2D

| InChI=1S/C12H24N2O2/c1-9(10-5-6-10)14-16-8-11(15)7-13-12(2,3)4/h10-11,13,15H,5-8H2,1-4H3/b14-9+

| InChIKey= IYQDIWRBEQWANY-NTEUORMPSA-N

| SMILES =C/C(=N\OCC(CNC(C)(C)C)O)/C1CC1 }}

|Section2={{Chembox Properties

| C=12 | H=24 | N=2 | O=2

| Appearance =

| Density =

| MeltingPt =

| BoilingPt =

| Solubility = }}

|Section3={{Chembox Hazards

| MainHazards =

| FlashPt =

| AutoignitionPt = }}

}}

Falintolol is a beta-adrenergic receptor antagonist.{{cite journal | vauthors = Conti P, Dallanoce C, De Amici M, De Micheli C, Klotz KN | title = Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists | journal = Bioorganic & Medicinal Chemistry | volume = 6 | issue = 4 | pages = 401–8 | date = April 1998 | pmid = 9597184 | doi = 10.1016/s0968-0896(97)10051-7 }}